Two Cases of CNS Atypical Theratoid Rhabdoid Tumor and Review of Literature

Czech version

Authors: H. Zítek ¹; D. Sumerauer ²; J. Zámečník ³; P. Vachata ¹; M. Sameš ¹; A. Puchmajerová ⁴
Authors‘ workplace: Neurochirugická klinika UJEP a Masarykova nemocnice v Ústí nad Labem, o. z, Krajská zdravotní, a. s., Ústí nad Labem ¹; Klinika dětské hematologie a onkologie 2. LF UK a FN Motol, Praha ²; Ústav patologie a molekulární medicíny, 2. LF UK a FN Motol, Praha ³; Ústav biologie a lékařské genetiky, 2. LF UK a FN Motol, Praha ⁴
Published in: Cesk Slov Neurol N 2017; 80/113(5): 605-607
Category: Letter to Editor
doi: https://doi.org/10.14735/amcsnn2017605

Overview

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Sources

1. Buscariollo DL, Park HS, Roberts KB, et al. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer 2012;118(17):4212– 19. doi: 10.1002/ cncr.27373.

2. Schrey D, Carceller Lechón F, Malietzis G, et al. Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature. J Neurooncol 2016;126(1):81– 90. doi: 10.1007/ s11060-015-1904-0.

3. Slavc I, Chocholous M, Leiss U, et al. Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992– 2012. Cancer Med 2014;3(1):91– 100. doi: 10.1002/ cam4.161.

4. DiPatri AJ, Sredni ST, Grahovac G, et al. Atypical teratoid rhabdoid tumors of the posterior fossa in children. Childs Nerv Syst 2015;31(10):1717– 28. doi: 10.1007/ s00381-015-2844-x.

5. Ostrom QT, Chen Y, M de Blank P, et al. The de-scriptive epidemiology of atypical teratoid/ rhabdoid tumors in the United States, 2001-2010. Neuro Oncol 2014;16(10):1392– 9. doi: 10.1093/ neuonc/ nou090.

6. Lafay-Cousin L, Hawkins C, Carret AS, et al. Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience. Eur J Cancer 2012;48(3):353– 9. doi: 10.1016/ j.ejca.2011.09.005.

7. Dufour C, Beaugrand A, Le Deley MC, et al. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 2012;118(15):3812– 21. doi: 10.1002/ cncr.26684.

8. Chi SN, Zimmerman MA, Yao X, et al. Intensive multimodality treatment for children with newly diagnos-ed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2009;27(3):385– 9. doi: 10.1200/ JCO.2008.18.7724.

9. von Hoff K, Hinkes B, Dannenmann-Stern E, et al. Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/ RT) of the CNS diag-nosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 2011 Dec 1;57(6):978– 85. doi: 10.1002/ pbc.23236.

10. Pai Panandiker AS, Merchant TE, Beltran C, et al. Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. Int J Radiat Oncol Biol Phys 2012;82(5):1756– 63. doi: 10.1016/ j.ijrobp.2011.02.059.